In vivo modulation of the allogeneic immune response by human fetal kidneys: The role of cytokines, chemokines, and cytolytic effector molecules

Transplantation

Volumn 69, Issue 7, 2000, Pages 1470-1478

  Dekel, Benjamin ^a,b   Marcus, Hadar ^a   Herzel, Ben Hur ^a   Böcher, Wulf O ^a   Passwell, Justen H ^b   Reisner, Yair ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CYTOKINE; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; EFFECTOR CELL; FETUS; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; KIDNEY GRAFT REJECTION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSPLANTATION;

EID: 0034656074     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004150-00044     Document Type: Article

References (43)

1. Foglia RP, Dipreta J, Statter MB, Donahoe PK. Fetal allograft survival in immunocompetent recipients is age dependent and organ specific. Ann Surg 1986; 204: 402.
2. Velasco AL, Hegre OD. Decreased immunogenicity of fetal kidneys: the role of passenger leukocytes. J Pediatr Surg 1989; 24: 59.
3. Lubin I, Segall H, Marcus H, et al. Engraftment of human peripheral blood lymphocytes in normal strains of mice. Blood 1994; 83: 2368.
4. Lubin I, Segall H, Erlich P, et al. Conversion of normal rats into SCID-like animals by means of bone marrow transplantation from SCID murine donor allows engraftment of human peripheral blood lymphocytes. Transplantation 1995; 60: 740.
5. Marcus H, David M, Canaan A, et al. Human/mouse radiation chimera are capable of mounting a human primary humoral response. Blood 1995; 86: 398.
6. Segall H, Lubin I, Marcus H, Canaan A, Reisner Y. Generation of primary antigen-specific human cytotoxic T lymphocytes in human/mouse radiation chimera. Blood 1996; 88: 721.
7. Burakova T, Marcus H, Canaan A, et al. Engrafted human T and B lymphocytes form mixed follicles in lymphoid organs of human/mouse and human/rat radiation chimera. Transplantation 1997; 63: 1166.
8. Bocher WO, Marcus H, Shakarchy R, et al. Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo. Immunology 1999; 96: 634.
9. The Trimera mouse: generating human monoclonal antibodies and an animal model for human diseases. Trends Biotechnol 1998; 166: 242.
10. Dekel B, Burakova T, Marcus H, Reisner Y, Dagan S. Engraftment of human kidney tissue in rat radiation chimera. I. A new model of human kidney allograft rejection. Transplantation 1997; 64: 1541.
11. Dekel B, Burakova T, Ben-Hur H, et al. Engraftment of human kidney tissue in rat radiation chimera. II. Human fetal kidneys display reduced immunogenicity to adoptively transferred human peripheral blood mononuclear cells and exhibit rapid growth and development. Transplantation 1997; 64: 1550.
12. Dekel B, Marcus H, Bocher WO, Yussim A, Reisner Y. Acute cellular rejection of human renal tissue by adoptive transfer of human PBMC: sequential gene expression of cytokines, chemokines, and cytolytic effector molecules and their regulation by CTLA4Ig. Int Immunol 1999; 11: 1673.
13. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14: 353.
14. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151: 4562.
15. de-Morales-Pinto MI, Vince GS, Flanagan BF, Hart CA, Johnson PM. Localization of IL-4 and IL-4 receptors in the human term placenta, decidua, and amniochorionic membranes. Immunology 1997; 90: 87.
16. Piccinni MP, Romagnani S. Regulation of fetal allograft survival by a hormone controlled Th1 and Th2-type cytokines. Immunol Res 1996; 15: 141.
17. Jarvis JN, Zhao L, Moore HT, Long PM, Vani-Gutta P. Regulation of cytokine mRNA expression in activated lymphocytes by human choriocarcinoma JAR cells. Cell Immunol 1996; 168: 251.
18. Bennet WA, Lagoo-Deenadayalan S, Brackin MN, Hale E, Cowan BD. Cytokine expression by models of human trophoblast as assessed by a semiquantitative reverse transcription-polymerase chain reaction technique. Am J Reprod Immunol 1996; 36: 285.
19. Levite M, Zinger H, Zisman E, Reisner Y, Mozes E. Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus. Cell Immunol 1995; 162: 138.
20. Naveh MT, Almogi G, Livni N, Silver J. Estrogen receptors and biologic response in rat parathyroid tissue and C cells. J Clin Invest 1992; 90: 2434.
21. Kirk AD, Bollinger RR, Finn OJ. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection. Hum Immunol 1995; 43: 113.
22. Robinson E, Keystone EC, Schall TJ, Gillett N, Fish EN. Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1beta production by synovial T cells. Clin Exp Immunol 1995; 101: 398.
23. Giordano C, Stassi G, De-Maria R, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960.
24. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381: 661.
25. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF, Rajotte RV. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Transplantation 1995; 60: 368.
26. Baur FM, Brenner B, Goetze-Speer B, Neu S, Speer CP. Natural porcine surfactant down-regulates mRNA of TNF-alpha and TNF-alpha type II receptor in lipopolysaccharide-stimulated monocytes. Pediatr Res 1998; 44: 32.
27. Sharma VK, Bologa RM, Li B, et al. Molecular executors of cell death: differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts. Transplantation 1996; 62: 1860.
28. Kennedy MK, Torrance DS, Picha KS, Mohler KM. Analysis of cytokine mRNA expression in central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 1992; 149: 2496.
29. Blancho G, Gianello P, Germana S, Baetscher M, Sachs DH, LeGuern C. Molecular identification of porcine interleukin 10: regulation of expression in a kidney allograft model. Proc Natl Acad Sci USA 1995; 92: 2800.
30. Pattison J, Nelson PJ, Huie P, et al. RANTES chemokine expression in cell-mediated transplant rejection of the kidney. Lancet 1994; 343: 209.
31. Nadeau KC, Azuma H, Tinley NL. Sequential cytokine dynamics in chronic rejection of rat renal allografts: roles for cytokines RANTES and MCP-1. Proc Natl Acad Sci USA 1995; 92: 8729.
32. Kondo T, Novick AC, Toma H, Fairchild RL. Induction of chemokine gene expression during allogeneic skin graft rejection. Transplantation 1996; 61: 1750.
33. von-Luettichau I, Nelson PJ, Pattison JM, et al. RANTES chemokine expression in diseased and normal human tissues. Cytokine 1996; 8: 89.
34. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669.
35. Deckers JM, Van Der Woude FJ, Van Der Kooij SW, Daha MR. Synergistic effect of IL-1alpha, IFN-gamma, and TNF-alpha on RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol 1998; 9: 194.
36. Nelson PJ, Kim HT, Manning WC, Goralski TJ, Krensky AM. Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 1993; 151: 2601.
37. Loetscher P, Seitz M, Baggiolini M, Moser B. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996; 184: 569.
38. Krams SM, Egawa H, Quinn MF, Villaneuva JC, Garcia-Kennedy R, Martinez OM. Apoptosis as a mechanism of cell death in liver allograft rejection. Transplantation 1995; 59: 621.
39. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630.
40. Dekel B, Passwell JH, Reisner Y. Modulation of the immune response by fetal kidney allografts. Pediatr Nephrol 1999; 13: 974.
41. Strom TB, Roy-Chaudhury P, Manfro R, et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996; 8: 688.
42. Dallman MJ. Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplants in the adult. Curr Opin Immunol 1995; 7: 632.
43. Piccotti JR, Chan SY, VanBuskirk AM, Eichwald EJ, Bishop KD. Are Th2 helper lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? Transplantation 1997; 63: 619.